Rare diseases
Investigational molecules
Locations
Back to Greece1 008 clinical trials in Chaidari, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
GreeceStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
GreeceStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
GreeceStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
GreeceStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
GreeceStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
GreeceStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
GreeceStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
GreeceStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
GreeceStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
GreeceStudy of tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
GreeceStudy of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on squamous cell carcinoma of the head and neck, exploring combination therapy approaches that integrate immunotherapy with traditional treatments.
The study evaluates the effectiveness of combining nivolumab with standard cisplatin-radiotherapy, aiming to improve disease-free survival rates in patients with resected head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
